(Q45073090)

9 December 2017

title

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia (English)

1 reference

9 December 2017

1 reference

1 reference

R F Schlenk

1

1 reference

9 December 2017

S Fröhling

2

1 reference

9 December 2017

F Hartmann

3

1 reference

9 December 2017

J Th Fischer

4

1 reference

9 December 2017

A Glasmacher

5

1 reference

9 December 2017

F del Valle

6

1 reference

9 December 2017

W Grimminger

7

1 reference

9 December 2017

K Götze

8

1 reference

9 December 2017

C Waterhouse

9

1 reference

9 December 2017

R Schoch

10

1 reference

9 December 2017

H Pralle

11

1 reference

9 December 2017

H G Mergenthaler

12

1 reference

9 December 2017

M Hensel

13

1 reference

9 December 2017

E Koller

14

1 reference

9 December 2017

H Kirchen

15

1 reference

9 December 2017

J Preiss

16

1 reference

9 December 2017

H Salwender

17

1 reference

9 December 2017

H G Biedermann

18

1 reference

9 December 2017

S Kremers

19

1 reference

9 December 2017

F Griesinger

20

1 reference

9 December 2017

A Benner

21

1 reference

9 December 2017

B Addamo

22

1 reference

9 December 2017

K Döhner

23

1 reference

9 December 2017

R Haas

24

1 reference

9 December 2017

H Döhner

25

1 reference

9 December 2017

AML Study Group Ulm

26

1 reference

9 December 2017

publication date

1 November 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

18

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

1798-1803

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403528

9 December 2017

exact match

0 references

cites work

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Cox's Regression Model for Counting Processes: A Large Sample Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Cytokine-regulated expression of survivin in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

7 January 2021

p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

7 January 2021

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

7 January 2021

Censoring distributions as a measure of follow-up in survival analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403528

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403528

1 reference

Dimensions Publication ID

9 December 2017

1017032889

0 references

1 reference